Enanta Pharmaceuticals (ENTA) Assets Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57% |
| Dec 31, 2025 | -5.49% |
| Sep 30, 2025 | -25.47% |
| Jun 30, 2025 | -24.52% |
| Mar 31, 2025 | -21.90% |
| Dec 31, 2024 | -18.64% |
| Sep 30, 2024 | -18.52% |
| Jun 30, 2024 | -19.46% |
| Mar 31, 2024 | 26.69% |
| Dec 31, 2023 | 23.30% |
| Sep 30, 2023 | 23.14% |
| Jun 30, 2023 | 28.54% |
| Mar 31, 2023 | -19.76% |
| Dec 31, 2022 | -21.12% |
| Sep 30, 2022 | -14.44% |
| Jun 30, 2022 | -14.48% |
| Mar 31, 2022 | -13.03% |
| Dec 31, 2021 | -8.40% |
| Sep 30, 2021 | -9.74% |
| Jun 30, 2021 | -11.97% |
| Mar 31, 2021 | -8.91% |
| Dec 31, 2020 | -5.86% |
| Sep 30, 2020 | -0.75% |
| Jun 30, 2020 | 8.07% |
| Mar 31, 2020 | 11.25% |
| Dec 31, 2019 | 12.50% |
| Sep 30, 2019 | 18.25% |
| Jun 30, 2019 | 24.90% |
| Mar 31, 2019 | 30.15% |
| Dec 31, 2018 | 33.31% |
| Sep 30, 2018 | 26.82% |
| Jun 30, 2018 | 37.43% |
| Mar 31, 2018 | 27.14% |
| Dec 31, 2017 | 22.39% |
| Sep 30, 2017 | 16.13% |
| Jun 30, 2017 | -2.16% |
| Mar 31, 2017 | -0.94% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 14.33% |
| Jun 30, 2016 | 18.57% |
| Mar 31, 2016 | 14.52% |
| Dec 31, 2015 | 29.22% |
| Sep 30, 2015 | 58.29% |
| Jun 30, 2015 | 49.06% |
| Mar 31, 2015 | 126.94% |
| Dec 31, 2014 | 95.56% |
| Sep 30, 2014 | 32.86% |
| Jun 30, 2014 | 33.29% |
| Mar 31, 2014 | -13.76% |
| Sep 30, 2013 | 124.25% |